Antitumor activity of the selective ALK inhibitor alectinib in models of intracranial metastases

Authors: Tatsushi Kodama, Masami Hasegawa, Kenji Takanashi, Yuji Sakurai, Osamu Kondoh, Hiroshi Sakamoto - Cancer Chemotherapy and Pharmacology 2014 cited by 242